Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 17/20 | 0.37 |
| ▸ | GSK3B | P49841 | 15/20 | 0.37 |
| ▸ | WNT1 | P04628 | 7/20 | 0.36 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.33 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23916735 | 0.81 | DYRK1A (0.37) | DYRK1AGSK3BWNT1ABL1 | |
| SCHEMBL23048909 | 0.77 | DYRK1A (0.42) | DYRK1AGSK3BWNT1ABL1 | |
| SCHEMBL19546592 | 0.77 | GSK3B (0.65) | DYRK1AGSK3BWNT1 | |
| SCHEMBL23916074 | 0.76 | DYRK1A (0.59) | DYRK1AGSK3BWNT1 | |
| SCHEMBL23916135 | 0.76 | DYRK1A (0.43) | DYRK1AGSK3BWNT1ABL1 | |
| SCHEMBL23916939 | 0.76 | DYRK1A (0.44) | DYRK1AGSK3BWNT1ABL1 | |
| SCHEMBL23916635 | 0.75 | DYRK1A (0.47) | DYRK1AGSK3BWNT1ABL1 | |
| SCHEMBL23916310 | 0.75 | GSK3B (0.59) | DYRK1AGSK3BWNT1 | |
| SCHEMBL23916048 | 0.74 | DYRK1A (0.61) | DYRK1AGSK3BWNT1 | |
| SCHEMBL23048669 | 0.74 | NNMT (0.38) | DYRK1AGSK3BWNT1ABL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892276-A1 | ISOQUINOLIN-3-YL CARBOXAMIDES AS WNT INHIBITORS | BioSplice Therapeutics, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |